Weight-Loss Drugs Like Ozempic May Come With an Unexpected Cost

A Rice University study found that people who lost weight with GLP-1 drugs like Ozempic and Wegovy were judged more harshly than those who lost weight through diet and exercise.

Participants also reacted more negatively to people who regained weight, suggesting weight stigma can persist even after medical treatment.

The researchers say this new kind of stigma could affect mental health, willingness to seek care, and broader acceptance of obesity medications.